MFN2 and chronic obstructive pulmonary disease: This is supported by findings in chronic obstructive pulmonary disease studies where Leflunomide recovered MFN2 expression previously reduced in lung tissues and alveolar cells exposed to cigarette smoke extract (CSE [48]).